Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer.
作者信息
Yamazaki Hideya, Masui Koji, Suzuki Gen, Yoshida Ken
机构信息
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, 465 Kajiicho Kawaramachi Hirokoji, Kamigyo-ku, Kyoto 602-8566 Japan.
Department of Radiology, Kansai Medical University, Hirakata 573-1010, Japan.
出版信息
Clin Transl Radiat Oncol. 2020 Jun 5;24:10. doi: 10.1016/j.ctro.2020.05.011. eCollection 2020 Sep.
Abstract
摘要
相似文献
1
Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer.对于临床局限性前列腺癌，高剂量率近距离放疗增敏的生化控制效果低于低剂量率近距离放疗增敏，这一结果出乎意料。
Clin Transl Radiat Oncol. 2020 Jun 5;24:10. doi: 10.1016/j.ctro.2020.05.011. eCollection 2020 Sep.
2
Response to 'Unexpected lower biochemical control of high-dose-rate brachytherapy boost than low-dose-rate brachytherapy boost for clinically localized prostate cancer'.对“关于临床局限性前列腺癌，高剂量率近距离放疗增敏比低剂量率近距离放疗增敏的生化控制效果意外更低”的回应
Clin Transl Radiat Oncol. 2020 Jun 10;24:52. doi: 10.1016/j.ctro.2020.06.001. eCollection 2020 Sep.
3
4
A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients.高剂量率近距离放疗联合低分割外照射放疗可使局限性中高危前列腺癌患者获得较高的无生化复发生存率。
Radiother Oncol. 2016 Nov;121(2):299-303. doi: 10.1016/j.radonc.2016.09.016. Epub 2016 Oct 28.
5
A comparative analysis of overall survival between high-dose-rate and low-dose-rate brachytherapy boosts for unfavorable-risk prostate cancer.高剂量率与低剂量率近距离放射治疗对高危前列腺癌患者总生存期的比较分析
Brachytherapy. 2019 Mar-Apr;18(2):186-191. doi: 10.1016/j.brachy.2018.12.007. Epub 2019 Jan 10.
6
Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.前瞻性剂量递增 II 期试验的长期结果：间质脉冲剂量率近距离放疗作为中高危前列腺癌的增敏剂。
Radiother Oncol. 2012 Aug;104(2):181-6. doi: 10.1016/j.radonc.2012.07.003. Epub 2012 Jul 30.
7
Cost-effectiveness of prostate boost with high-dose-rate brachytherapy versus intensity-modulated radiation therapy in the treatment of intermediate-high risk prostate cancer.高剂量率近距离放射治疗与调强放射治疗前列腺局部加量在治疗中高危前列腺癌中的成本效益分析
Brachytherapy. 2018 Nov-Dec;17(6):852-857. doi: 10.1016/j.brachy.2018.07.009. Epub 2018 Jul 31.
8
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors.适形高剂量率近距离放射治疗可改善前列腺癌及预后不良因素患者的生化控制并提高病因特异性生存率。
J Urol. 2003 Mar;169(3):974-9; discussion 979-80. doi: 10.1097/01.ju.0000052720.62999.a9.
9
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.雄激素抑制联合选择性淋巴结及剂量递增放射治疗（ASCENDE-RT试验）：一项针对高风险和中风险前列腺癌的随机试验的生存终点分析，该试验比较了低剂量率近距离放疗增敏与剂量递增外照射增敏。
Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285. doi: 10.1016/j.ijrobp.2016.11.026. Epub 2016 Nov 24.
10
Combined external beam radiotherapy and Pd-103 brachytherapy boost improves biochemical failure free survival in patients with clinically localized prostate cancer: results of a matched pair analysis.外照射放疗联合钯-103近距离放疗增敏可提高临床局限性前列腺癌患者的无生化失败生存率：配对分析结果
Prostate. 2005 Jan 1;62(1):54-60. doi: 10.1002/pros.20118.
本文引用的文献
1
A comparison of outcomes for patients with intermediate and high risk prostate cancer treated with low dose rate and high dose rate brachytherapy in combination with external beam radiotherapy.低剂量率和高剂量率近距离放疗联合外照射放疗治疗中高危前列腺癌患者的疗效比较
Clin Transl Radiat Oncol. 2019 Oct 14;20:1-8. doi: 10.1016/j.ctro.2019.10.001. eCollection 2020 Jan.
2
High-dose-rate brachytherapy monotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer.高剂量率近距离放射治疗单药治疗与低剂量率近距离放射治疗联合或不联合外部束放射治疗局限性前列腺癌的比较。
Radiother Oncol. 2019 Mar;132:162-170. doi: 10.1016/j.radonc.2018.10.020. Epub 2018 Nov 8.
3
A combined single high-dose rate brachytherapy boost with hypofractionated external beam radiotherapy results in a high rate of biochemical disease free survival in localised intermediate and high risk prostate cancer patients.高剂量率近距离放疗联合低分割外照射放疗可使局限性中高危前列腺癌患者获得较高的无生化复发生存率。
Radiother Oncol. 2016 Nov;121(2):299-303. doi: 10.1016/j.radonc.2016.09.016. Epub 2016 Oct 28.
4
Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 years.高剂量率近距离放射治疗中高危前列腺癌的长期结局，中位随访10年。
BJU Int. 2017 Jul;120(1):56-60. doi: 10.1111/bju.13659. Epub 2016 Oct 7.
5
High-dose-rate interstitial brachytherapy as a monotherapy for localized prostate cancer: treatment description and preliminary results of a phase I/II clinical trial.高剂量率组织间近距离放射疗法作为局限性前列腺癌的单一疗法：一项I/II期临床试验的治疗描述及初步结果
Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):675-81. doi: 10.1016/s0360-3016(00)00687-8.
6
Phase III trial of high and low dose rate interstitial radiotherapy for early oral tongue cancer.早期口腔舌癌高剂量率与低剂量率组织间放射治疗的III期试验
Int J Radiat Oncol Biol Phys. 1996 Dec 1;36(5):1201-4. doi: 10.1016/s0360-3016(96)00420-8.
Zotero 插件